Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients With Current Malignancy

Little is known about the risk of thrombolysis in patients with malignancy, because these patients have been excluded from most clinical trials. We reviewed our acute ischemic stroke (AIS) database for clinical outcomes and complications in patients with current malignancy (CM) who received thrombol...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of stroke and cerebrovascular diseases 2011-03, Vol.20 (2), p.124-130
Hauptverfasser:	Masrur, Shihab, MD, Abdullah, Abdul R., MD, Smith, Eric E., MD, MPH, Hidalgo, Renzo, MD, El-Ghandour, Ahmed, MD, Rordorf, Guy, MD, Schwamm, Lee H., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Boston Brain Ischemia - complications Brain Ischemia - drug therapy Brain Ischemia - mortality Cardiovascular Chi-Square Distribution Comorbidity Female Fibrinolytic Agents - administration & dosage Fibrinolytic Agents - adverse effects Hospital Mortality Humans ICH in-hospital mortality Intracranial Hemorrhages - chemically induced Intracranial Hemorrhages - mortality Logistic Models Male Neoplasms - complications Neoplasms - mortality Neurology Odds Ratio Retrospective Studies Risk Assessment Risk Factors Stroke - drug therapy Stroke - etiology Stroke - mortality thrombolysis Thrombolytic Therapy - adverse effects Thrombolytic Therapy - mortality Tissue Plasminogen Activator - administration & dosage Tissue Plasminogen Activator - adverse effects tPA Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!